MLICM
OLMA icon

Metropolitan Life Insurance Company (MetLife)’s Olema Pharmaceuticals OLMA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,545
Closed -$17.5K – 1458
2024
Q1 		$17.5K Hold
1,545
– – ﹤0.01% 1929
2023
Q4 		$21.7K Hold
1,545
– – ﹤0.01% 1886
2023
Q3 		$19.1K Hold
1,545
– – ﹤0.01% 1921
2023
Q2 		$14K Buy
+1,545
New +$9.33K ﹤0.01% 2117
2022
Q1 		– Sell
-7,243
Closed -$67.8K – 2549
2021
Q4 		$67.8K Hold
7,243
– – ﹤0.01% 2652
2021
Q3 		$200K Buy
7,243
+2,629
+57% +$71K ﹤0.01% 2070
2021
Q2 		$129K Buy
4,614
+513
+13% +$14.6K ﹤0.01% 2451
2021
Q1 		$136K Buy
+4,101
New +$176K ﹤0.01% 2273

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OLMA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Olema Pharmaceuticals (OLMA) in Q2 2024, closing a stake of 1,545 shares — an estimated $17.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OLMA in Q1 2021 and held it in 8 quarters. The position peaked at $200K in Q3 2021. 128 funds tracked by Wall St. Rank hold OLMA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Olema Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,545 Olema Pharmaceuticals shares in Q2 2024, an estimated $17.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Olema Pharmaceuticals in Q1 2021 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Olema Pharmaceuticals position peaked at $200K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.